Position in SCLX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$3,156
-$2,626 QoQ
Shares Held
474
0.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MCF Advisors LLC holds $24,166,889 across 16 Drug Manufacturers - General names. SCLX ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
24,429 | $5,971,424 | |
| 2 | AMGN |
Amgen Inc
|
11,665 | $4,104,330 | |
| 3 | LLY |
ELI LILLY & Co
|
3,526 | $3,243,109 | |
| 4 | MRK |
Merck & Co., Inc.
|
24,309 | $2,924,129 | |
| 5 | ABBV |
AbbVie Inc.
|
13,037 | $2,835,417 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
19,974 | $2,783,776 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
16,168 | $980,589 | |
| 8 | PFE |
Pfizer Inc
|
32,618 | $915,913 |
All Filings in SCLX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,156 | 474 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $5,782 | 474 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $9,328 | 474 | Shares | Sole | 2025-11-05 | |
| No filing history on record for this holder in this stock. | ||||||